DUAL METALLOPROTEASE INHIBITORS .6. INCORPORATION OF BICYCLIC AND SUBSTITUTED MONOCYCLIC AZEPINONES AS DIPEPTIDE SURROGATES IN ANGIOTENSIN-CONVERTING ENZYME NEUTRAL ENDOPEPTIDASE INHIBITORS

Citation
Ja. Robl et al., DUAL METALLOPROTEASE INHIBITORS .6. INCORPORATION OF BICYCLIC AND SUBSTITUTED MONOCYCLIC AZEPINONES AS DIPEPTIDE SURROGATES IN ANGIOTENSIN-CONVERTING ENZYME NEUTRAL ENDOPEPTIDASE INHIBITORS, Journal of medicinal chemistry, 39(2), 1996, pp. 494-502
Citations number
42
Categorie Soggetti
Chemistry Medicinal
ISSN journal
00222623
Volume
39
Issue
2
Year of publication
1996
Pages
494 - 502
Database
ISI
SICI code
0022-2623(1996)39:2<494:DMI.IO>2.0.ZU;2-1
Abstract
A series of substituted monocyclic and bicyclic azepinones were incorp orated as dipeptide surrogates in mercaptoacetyl dipeptides with the d esire to generate a single compound which would potently inhibit both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). M any of these compounds displayed excellent potency against both enzyme s. Two of the most potent compounds, monocyclic azepinone 2n and bicyc lic azepinone 3q, demonstrated a high level of activity versus ACE and NEP both in vitro and in vivo.